NCT01511003View on ClinicalTrials.gov

A Study is to Assess Efficacy and Safety of Tacrolimus in Active Rheumatoid Arthritis Patients Who Showed Unsuccessful Response to Existing Disease Modifying Antirheumatic Drugs (DMARDs)

PHASE4CompletedINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

December 5, 2011

Primary Completion Date

May 11, 2015

Study Completion Date

May 11, 2015

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Tacrolimus

oral

Trial Locations (4)

Unknown

Busan

Daejeon

Gyeonggi-do

Seoul

Sponsors
All Listed Sponsors
collaborator

Astellas Pharma Korea, Inc.

INDUSTRY

lead

Astellas Pharma Inc

INDUSTRY

NCT01511003 - A Study is to Assess Efficacy and Safety of Tacrolimus in Active Rheumatoid Arthritis Patients Who Showed Unsuccessful Response to Existing Disease Modifying Antirheumatic Drugs (DMARDs) | Biotech Hunter | Biotech Hunter